| Literature DB >> 29626320 |
Mélanie Gaubert1, Marion Marlinge2,3, Marine Alessandrini4, Marc Laine1, Laurent Bonello1, Julien Fromonot2,3, Jennifer Cautela1, Franck Thuny1, Jeremie Barraud1, Giovanna Mottola2,3, Pascal Rossi3, Emmanuel Fenouillet3,5, Jean Ruf3, Régis Guieu6,7,8, Franck Paganelli1.
Abstract
The role of serum uric acid in coronary artery disease has been extensively investigated. It was suggested that serum uric acid level (SUA) is an independent predictor of endothelial dysfunction and related to coronary artery lesions. However, the relationship between SUA and severity of coronary atherosclerosis evaluated via endothelial dysfunction using peripheral arterial tone (PAT) and the reactive hyperhemia index (RHI) has not been investigated during a first episode of acute coronary syndrome (ACS). The aim of our study was to address this point. We prospectively enrolled 80 patients with a first episode of ACS in a single-center observational study. All patients underwent coronary angiography, evaluation of endothelial function via the RHI, and SUA measurement. The severity of the coronary artery lesion was assessed angiographically, and patients were classified in three groups based on the extent of disease and Gensini and SYNTAX scores. Endothelial function was considered abnormal if RHI < 1.67. We identified a linear correlation between SUA and RHI (R2 = 0.66 P < 0.001). In multivariable analyses, SUA remained associated with RHI, even after adjustment for traditional cardiovascular risk factors and renal function. SUA was associated with severity of coronary artery disease. SUA is associated with severity of coronary atherosclerosis in patients with asymptomatic hyperuricemia. This inexpensive, readily measured biological parameter may be useful to monitor ACS patients.Entities:
Keywords: Coronary artery disease; Endothelial dysfunction; First episode of acute coronary syndrome; Serum uric acid
Mesh:
Substances:
Year: 2018 PMID: 29626320 PMCID: PMC5940631 DOI: 10.1007/s11302-018-9604-9
Source DB: PubMed Journal: Purinergic Signal ISSN: 1573-9538 Impact factor: 3.765